Mauricio Maia

Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products

Anthony R. Mire‐Sluis, Yu Chen Barrett, Viswanath Devanarayan et al. · Journal of Immunological Methods · 2004 · 621 citations

Life Sciences, Biotechnology, Immunology +13

Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of RG7667, a Combination Monoclonal Antibody, for Prevention of Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

Julie H. Ishida, Anita Patel, Aneesh K. Mehta et al. · Antimicrobial Agents and Chemotherapy · 2016 · 96 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Drug Target Interference in Immunogenicity Assays: Recommendations and Mitigation Strategies

Zhandong Don Zhong, Adrienne Clements‐Egan, Boris Gorovits et al. · The AAPS Journal · 2017 · 84 citations · Full text

Pharmacy, Pharmaceutics, Pharmacokinetics +17

A Therapeutic Anti–VEGF Antibody with Increased Potency Independent of Pharmacokinetic Half-life

Yik A. Yeung, Xiumin Wu, Arthur E. Reyes et al. · Cancer Research · 2010 · 79 citations

Pharmacy, Oncology, Pharmacology +17

Phase 2 Randomized Trial of the Safety and Efficacy of MHAA4549A, a Broadly Neutralizing Monoclonal Antibody, in a Human Influenza A Virus Challenge Model

Jacqueline McBride, Jeremy J. Lim, Tracy Burgess et al. · Antimicrobial Agents and Chemotherapy · 2017 · 78 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +15